|
Volumn 47, Issue 3, 1999, Pages 284-290
|
Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANEMIC AGENT;
IRON;
RECOMBINANT ERYTHROPOIETIN;
ADULT;
ARTICLE;
BLOOD;
BLOOD TRANSFUSION;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HOSPITALIZATION;
HUMAN;
IRON DEFICIENCY ANEMIA;
KIDNEY FUNCTION TEST;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
ANEMIA, IRON-DEFICIENCY;
BLOOD TRANSFUSION;
COMBINED MODALITY THERAPY;
ERYTHROPOIETIN, RECOMBINANT;
FEMALE;
HEMATINICS;
HUMANS;
IRON;
KIDNEY FAILURE, CHRONIC;
KIDNEY FUNCTION TESTS;
MALE;
MIDDLE AGED;
PROGNOSIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 0033085835
PISSN: 00045772
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|